Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Community Engagement Indaba a platform to engage Free State community stakeholders
2016-12-14

Description: Community Engagement Indaba  Tags: Community Engagement Indaba  

Teaching women handicrafts for self-sustainability.

The University of the Free State (UFS), through the office of Community Engagement and in collaboration with Bloemshelter, has hosted the Community Engagement Indaba in Bloemfontein since 2013. This is a platform where stakeholders in business, welfare and other community organisations can network and hold dialogues that can bring about solutions to some of the societal challenges faced by Free State communities.

Bloemshelter is an independent and registered Non-Profit Organisation (NPO) and Public Benefit Organisation that provides shelter for the homeless; catering for women, women with children, the elderly, men and frail persons. The shelter accommodates up to 100 people in both the male and female shelters. The growing partnership it has with the UFS over recent years has grown its ability to reach out to local communities in a more effective way.

At the 2016 Community Engagement Indaba on 25-27 August, a number of stakeholders were invited to participate in the skills development action-learning workshops, under the theme: Unlocking Human Potential and Creating Jobs. This was a platform to strengthen the university’s partnerships with NPOs and other advocacy groups in the province. UFS academics, Community Service Learning students and community partners gave their presentations while the Director of Community Engagement, Bishop Billyboy Ramahlele, offered carpentry training. Among the participating collaborators was the Free State Department of Education, Celebrate Recovery, ABSA Bank, The Shunammite Foundation, Lebone Village, and Global University of Lifelong Learning (GULL).

Those who attended received certificates that will in future help them build a portfolio of learning evidence. The conference was about creating meaning, igniting learning, propelling movement, inspiring hope and encouraging sharing by bringing together students, academics and members of communities. The next Community Engagement Indaba will be held next year, on a date that will be announced early in the year.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept